These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20720475)

  • 21. Tigecycline-induced pancreatitis.
    Lipshitz J; Kruh J; Cheung P; Cassagnol M
    J Clin Gastroenterol; 2009 Jan; 43(1):93. PubMed ID: 18769361
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline.
    Pieringer H; Schmekal B; Biesenbach G; Pohanka E
    Ann Hematol; 2010 Oct; 89(10):1063-4. PubMed ID: 20174923
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline.
    Raad I; Hachem R; Hanna H; Girgawy E; Rolston K; Whimbey E; Husni R; Bodey G
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3202-4. PubMed ID: 11600379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tigecycline treatment of multi-drug-resistant Corynebacterium jeikeium infection in a child with relapsing and refractory acute lymphoblastic leukemia.
    Dinleyici EC; Yargic ZA; Bor O; Kiremitci A; Durmaz G
    Pediatr Blood Cancer; 2010 Aug; 55(2):349-51. PubMed ID: 20582969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections.
    Fritsche TR; Kirby JT; Jones RN
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):201-9. PubMed ID: 15246511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotics in acute necrotising pancreatitis.
    Cullimore J; Cotter L; Gonzalez A
    Lancet; 2008 Mar; 371(9618):1072; author reply 1072. PubMed ID: 18374839
    [No Abstract]   [Full Text] [Related]  

  • 27. Tigecycline: benefits and risks.
    Cai Y; Wang R
    Lancet Infect Dis; 2011 Nov; 11(11):804-5. PubMed ID: 21784707
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of tigecycline pleurodesis: a comparative experimental study.
    Daddi N; Vannucci J; Maggio C; Giontella A; Bravi I; Marziani F; Capozzi R; Ragusa M; Bufalari A; Puma F
    J Surg Res; 2011 Aug; 169(2):e109-18. PubMed ID: 20934718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.
    Sacchidanand S; Penn RL; Embil JM; Campos ME; Curcio D; Ellis-Grosse E; Loh E; Rose G
    Int J Infect Dis; 2005 Sep; 9(5):251-61. PubMed ID: 16099700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of tigecycline against bacterial isolates from intensive care units in a teaching hospital in Central Saudi Arabia.
    Somily AM; Al-Khattaf AS; Kambal AM
    Saudi Med J; 2010 Jan; 31(1):18-24. PubMed ID: 20062893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tigecycline: place in therapy and important considerations.
    Garrelts JC; Schroeder T
    Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial.
    Rodloff AC; Leclercq R; Debbia EA; Cantón R; Oppenheim BA; Dowzicky MJ
    Clin Microbiol Infect; 2008 Apr; 14(4):307-14. PubMed ID: 18261126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tigecycline: a single antibiotic for polymicrobial infections.
    Pankey GA; Steele RW
    Pediatr Infect Dis J; 2007 Jan; 26(1):77-8. PubMed ID: 17195711
    [No Abstract]   [Full Text] [Related]  

  • 35. Resistance to a beta-lactam antibiotic appearing during therapy for enterobacter cloacae sepsis in a child.
    Muñoz M; Márquez C; Taguas-Casaño M; Soult JA; López-Castilla JD; Alvarez-Silván AM
    Med Pediatr Oncol; 2003 Jan; 40(1):62-3. PubMed ID: 12426691
    [No Abstract]   [Full Text] [Related]  

  • 36. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
    Betriu C; Rodríguez-Avial I; Gómez M; Culebras E; López F; Alvarez J; Picazo JJ;
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of tigecycline trials announced.
    McConnell J
    Lancet Infect Dis; 2004 Dec; 4(12):717. PubMed ID: 15593443
    [No Abstract]   [Full Text] [Related]  

  • 39. Tigecycline-based prolonged salvage therapy in patients presenting with complex bone and joint infection.
    Wach J; Dinh A; Dutronc H; Sipahi OR; Candevir A; Valour F; Zeller V; Lustig S; Laurent F; Chidiac C; Ferry T;
    Med Mal Infect; 2018 Feb; 48(1):53-57. PubMed ID: 29031650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.